Synvisc-One Bacteria Contaminate Revealed
Last December, Sanofi Genzyme recalled 12,380 Synvisc-One syringes from lot number 7RSL021 sold nationwide in 36 states from October 25, 2017, through November 7, 2017, due to microbial contamination. Now, through a Class 2 recall, the company has revealed the Synvisc-One bacterium that has caused thousands of people to experience pain so intense that they are
Read More
Synvisc-One Lawsuit
There is a possible Synvisc-One lawsuit in the not-so-distant future. In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One, because of microbial contamination of lot number 7RSL021 sold in 36 U.S. states from October 25, 2017, through November 7, 2017. This recalled lot equates to 12,380 syringes. Investigators pinpointed that the microbe is a common airborne organism, which causes
Read More
Synvisc-One Recall
Attention osteoarthritis injection users: there has been a Synvisc-One recall. In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One. This is a result of microbial contamination of lot number 7RSL021 sold in 36 U.S. states from October 25, 2017, through November 7, 2017. This recalled lot equates to 12,380 syringes. Investigators pinpointed that the microbe is a common airborne
Read More
Synvisc-One Knee Injection Recall
Manufacturer Sanofi Genzyme voluntarily recalled a lot of almost 20,000 Synvisc-One knee injection syringes when discovered that they tested positive for microbial contamination. This lot, number 7RSL021, was sold in the United States from October 25, 2017, through November 7, 2017. About Synvisc-One The FDA approved Synvisc-One in 2009 to help with pain from knee osteoarthritis.
Read More
Popular Arthritis Medications Can Lead to Disaster
Millions of people across the United States suffer from constant pain from arthritis. Consumers depend on arthritis medications like Actemra or Synvisc-One to help them lead a normal life. However, these medications aren’t completely safe. When their safety fails, these drugs hurt thousands of American consumers. About Actemra Introduced in 2010, Actemra treats rheumatoid arthritis. Unlike other
Read More
Synvisc-One Injections Contaminated with Microbes
In December 2017, Sanofi Genzyme voluntarily recalled Synvisc-One, as a result of an airborne microbial contamination of lot number 7RSL021 sold in the United States from October 25, 2017, through November 7, 2017. This recalled lot equates to over 12,000 syringes. About Synvisc-One Synvisc-One injections use hylan A fluid and hylan B gel, made from a substance called
Read More